Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Jan-23 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 700 | 859 | 1,172 | 2,328 | 1,479 | 1,512 | 1,845 | 2,656 | 7,347 | 5,761 | | 7,466 |
% Growth | NA | 22.8% | 36.3% | 98.7% | -36.5% | 2.2% | 22.0% | 44.0% | 176.6% | -21.6% | | |
| | | | | | | | | | | | |
Cost of Revenue | (467) | (574) | (792) | (1,527) | (1,059) | (1,020) | (1,216) | (1,975) | (6,006) | (6,077) | | (7,481) |
Gross Profit | 232 | 285 | 380 | 801 | 420 | 491 | 629 | 682 | 1,341 | (316) | | (15) |
% Revenue | 33.2% | 33.2% | 32.4% | 34.4% | 28.4% | 32.5% | 34.1% | 25.7% | 18.3% | -5.5% | | -0.2% |
| | | | | | | | | | | | |
Research and Development | (22) | (31) | (43) | (91) | (84) | (100) | (111) | (126) | (181) | (204) | | (201) |
Selling and Marketing | (23) | (23) | (29) | (43) | (27) | (30) | (40) | (60) | (78) | (84) | | (137) |
General and Admin | (48) | (67) | (87) | (210) | (1,049) | (160) | (119) | (189) | (252) | (142) | | (174) |
Other Inc / (Exp) | 23 | 32 | 41 | (16) | (1,494) | (42) | (46) | 49 | (50) | 83 | | 695 |
Total Operating Exp | (70) | (89) | (118) | (360) | (2,654) | (332) | (315) | (326) | (560) | (347) | | 183 |
| | | | | | | | | | | | |
Operating Income | 162 | 197 | 262 | 441 | (2,234) | 159 | 313 | 356 | 781 | (663) | | 168 |
% Revenue | 23.2% | 22.9% | 22.4% | 18.9% | -151.1% | 10.5% | 17.0% | 13.4% | 10.6% | -11.5% | | 2.2% |
| | | | | | | | | | | | |
Interest Expense | (1) | 6 | 4 | (5) | (20) | 85 | 73 | 103 | (47) | (42) | | (29) |
Pre-tax Income | 161 | 202 | 266 | 436 | (2,255) | 244 | 386 | 459 | 733 | (705) | | 139 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (24) | (29) | (37) | (64) | (74) | 266 | (57) | (60) | (87) | 122 | | 27 |
Net Income to Company | 137 | 174 | 229 | 371 | (2,328) | 510 | 329 | 399 | 646 | (583) | | 165 |
% Margin | 19.6% | 20.2% | 19.5% | 16.0% | -157.5% | 33.7% | 17.8% | 15.0% | 8.8% | -10.1% | | 2.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | (0) | 0 | (0) | 5 | 4 | 1 | (0) | (1) | 40 | | 5 |
Net Income to Stockholders | 137 | 174 | 229 | 371 | (2,324) | 514 | 330 | 399 | 645 | (543) | | 170 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 137 | 174 | 229 | 371 | (2,324) | 514 | 330 | 399 | 645 | (543) | | 170 |
% Margin | 19.6% | 20.2% | 19.5% | 15.9% | -157.2% | 34.0% | 17.9% | 15.0% | 8.8% | -9.4% | | 2.3% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.20 | 0.22 | 0.25 | 0.29 | (1.81) | 0.44 | 0.30 | 0.35 | 0.54 | (0.45) | | 0.14 |
Diluted EPS (Continuing Ops) | 0.20 | 0.22 | 0.25 | 0.29 | (1.81) | 0.44 | 0.30 | 0.35 | 0.54 | (0.45) | | 0.14 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 688.36 | 772.71 | 917.89 | 1,300.26 | 1,284.31 | 1,178.85 | 1,108.52 | 1,141.89 | 1,194.16 | 1,217.69 | | 1,223.24 |
WA Diluted Shares Out. | 688.36 | 772.71 | 917.89 | 1,300.26 | 1,284.31 | 1,178.85 | 1,108.52 | 1,144.51 | 1,204.64 | 1,217.69 | | 1,223.24 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 161 | 202 | 266 | 436 | (2,255) | 244 | 386 | 459 | 733 | (705) | | 139 |
Addback: Net Interest Expense | 1 | (6) | (4) | 5 | 20 | (85) | (73) | (103) | 47 | 42 | | 29 |
Addback: Other Non Operating Expenses, Total | 1 | (4) | (10) | 6 | (107) | 2 | 9 | 6 | (7) | (1) | | 12 |
Addback: Depreciation & Amortization | 26 | 30 | 53 | 112 | 136 | 124 | 118 | 130 | 199 | 263 | | 311 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 12 | 1,551 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | 0 | | (5) |
Addback: Gain (Loss) On Sale Of Assets | (0) | 0 | 2 | 0 | 0 | 21 | (0) | 3 | 101 | (0) | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 51 | 31 | 12 | 9 | 0 | 2 | | (593) |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (7) | (5) | 0 | (22) | (14) | (26) | 11 | (80) | (66) | (91) | | (144) |
Adjusted EBITDA | 182 | 218 | 307 | 549 | (618) | 312 | 464 | 423 | 1,009 | (491) | | (250) |
% Margin | 25.9% | 25.4% | 26.2% | 23.6% | -41.8% | 20.7% | 25.2% | 15.9% | 13.7% | -8.5% | | -3.4% |
| | | | | | | | | | | | |
Adjusted EBIT | 156 | 188 | 254 | 438 | (753) | 188 | 346 | 293 | 810 | (754) | | (561) |
% Margin | 22.2% | 21.9% | 21.7% | 18.8% | -51.0% | 12.4% | 18.7% | 11.0% | 11.0% | -13.1% | | -7.5% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 137 | 174 | 229 | 371 | (2,328) | 510 | 329 | 399 | 646 | (583) | | 165 |
Addback: Unusual Items | (8) | (4) | 2 | (10) | 1,588 | 26 | 23 | (69) | 36 | (90) | | (741) |
Less: Tax Benefit of Unusual Items (26%) | 2 | 1 | (1) | 3 | (413) | (7) | (6) | 18 | (9) | 23 | | 193 |
Adjusted Net Income | 131 | 170 | 230 | 364 | (1,154) | 530 | 346 | 348 | 673 | (649) | | (383) |
% Margin | 18.8% | 19.8% | 19.7% | 15.6% | -78.0% | 35.0% | 18.8% | 13.1% | 9.2% | -11.3% | | -5.1% |